Qingdao Baheal Medical INC. News

Qingdao Baheal Medical INC.: 2023 Qingdao Baiyang Pharmaceutical Co., Ltd issues convertible enterprise bonds on the growth board to unspecified investors, 2024 tracking rating report.

12:00 ET

Qingdao Baheal Medical INC.: Notice Regarding the Holding of the Second Extraordinary Shareholders' Meeting in 2024.

12:00 ET

Qingdao Baheal Medical INC.: Announcement Regarding the Reply to Shenzhen Stock Exchange's Inquiry Letter.

Jun 14 07:22 ET

Qingdao Baheal Medical INC.: Announcement on Revision of Certain Clauses of the Acquisition Agreement of Shanghai Baiyang Pharmaceutical Co., Ltd., Qingdao Baiyang Investment Group Co., Ltd., Qingdao Baiyang Yiren Investment Management Co., Ltd. and Beijing Baiyang Kanghe Technology Co., Ltd.

Jun 11 07:10 ET

Qingdao Baheal Medical INC.: Announcement on the resumption of stock conversion of Baiyang Convertible Bonds

May 28 06:54 ET

Qingdao Baheal Medical INC.: Announcement on the adjustment of Baiyang debt-for-equity conversion price

May 21 06:56 ET

Qingdao Baheal Medical INC.: Announcement on the suspension of share conversion of Baiyang Convertible Bonds during the 2023 equity distribution period

May 17 09:42 ET

Qingdao Baheal Medical INC.: Legal Opinions of Beijing Tianyuan Law Firm on the 2023 Annual General Meeting of Shareholders of Qingdao Baiyang Pharmaceutical Co., Ltd.

May 13 06:26 ET

Qingdao Baheal Medical INC.: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 13 06:26 ET

Baiyang Pharmaceutical: Announcement on Joint Investment with Professional Investment Institutions

Apr 23 06:13 ET

Baiyang Pharmaceutical: Special Report by Lixin Certified Public Accountants (Special General Partnership) on the Non-operating Capital Occupation and Other Related Capital Transactions of Qingdao Baiyang Pharmaceutical Co., Ltd.

Apr 22 12:00 ET

Baiyang Pharmaceutical: Announcement on the Use of Some Idle Own Funds to Entrust Financial Management

Apr 22 12:00 ET

Baiyang Pharmaceutical: Notice on Convening the 2023 Annual General Meeting of Shareholders

Apr 22 12:00 ET

Baiyang Pharmaceutical: 2023 Internal Control Evaluation Report

Apr 22 12:00 ET

Baiyang Pharmaceutical: Report on the Audit Committee of the Board of Directors on the performance of supervisory duties by accounting firms in 2023

Apr 22 12:00 ET

Baiyang Pharmaceutical: Announcement on the 2024 Interest Payment of Baiyang Convertible Bonds

Apr 8 06:24 ET

Baiyang Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the first quarter of 2024

Apr 1 03:46 ET

Baiyang Pharmaceutical: Notice on completing the registration of industrial and commercial changes and issuing a business license

Feb 22 04:04 ET

Baiyang Pharmaceutical: Legal Opinions of Beijing Tianyuan Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Qingdao Baiyang Pharmaceutical Co., Ltd.

Feb 5 04:14 ET

Baiyang Pharmaceutical: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders

Feb 5 04:14 ET